SEC Filing Summary: Sunshine Heart, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Sunshine Heart, Inc. on September 21, 2016. The filing addresses a critical corporate governance event regarding the company's listing status on The Nasdaq Capital Market. The registrant is incorporated in Delaware with principal executive offices in Eden Prairie, Minnesota.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance regarding stock listing standards rather than financial performance metrics.
Material Changes
The primary material change reported is the receipt of a delisting notice from the Listing Qualifications Staff of The NASDAQ Stock Market LLC. The notice cites the company's continued non-compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)), which mandates a closing bid price of at least $1.00. This non-compliance was based on the closing bid price over the 30 prior consecutive business days. The company had previously been granted a 180-day grace period ending September 19, 2016, to regain compliance, which it failed to achieve.
Outlook, Risks, and Management Commentary
Management intends to timely request a hearing before the Nasdaq Hearings Panel, an action that will stay any immediate delisting action. At the hearing, the company plans to present a strategy to evidence compliance with listing criteria and request an extension of time to do so. The filing explicitly states there can be no assurance that the Panel will grant continued listing or that the company will be able to meet the criteria within any granted timeframe. A press release regarding this notice was issued on September 23, 2016.
Investor Verification Checklist
- Verify the current status of the hearing request with the Nasdaq Hearings Panel.
- Monitor the company's stock price to determine if it has met the $1.00 minimum bid price requirement.
- Review the press release dated September 23, 2016 (Exhibit 99.1) for specific details on the compliance plan.
- Check for subsequent filings regarding the outcome of the hearing or potential transfer to the OTC markets.